Huiping Zhang, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry

PhD, Queen's University
MS, Tongji Medical University
BS, Central China Normal University



Huiping Zhang, PhD is a Professor in the Department of Psychiatry and the Department of Medicine (Section of Biomedical Genetics) at the Boston University Chobanian & Avedisian School of Medicine. He previously held academic appointments at Yale University School of Medicine, where he completed his postdoctoral training and advanced through roles as Research Associate Scientist (equivalent to Research Assistant Professor), Assistant Professor (tenure-track), and Research Scientist (equivalent to Research Associate Professor) before joining Boston University as an Associate Professor in 2017. Dr. Zhang’s research investigates the genetic and epigenetic mechanisms underlying substance use disorders (SUDs) and related psychiatric conditions. His work has been supported by multiple NIH awards, including a K99/R00, an R21, and two R01 grants from the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). He has also served as a subcontract Principal Investigator on two R01 projects funded by the National Institute of Child Health and Human Development (NICHD). In addition to his research, Dr. Zhang is actively engaged in academic publishing. He serves on the editorial boards of several peer-reviewed journals, including PLOS ONE, Frontiers in Genetics, Frontiers in Psychiatry, Frontiers in Cell and Developmental Biology, and Complex Psychiatry.

Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Biomedical Genetics

Member
Boston University
Genome Science Institute


Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder
03/01/2022 - 12/31/2026 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5R01AA029758-05

Association of maternal, fetal, and placental biomarkers with neonatal neuroimaging and development following in-utero opioid exposure
09/01/2023 - 08/31/2026 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD
1R01HD113143-01

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder
10/01/2018 - 05/31/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD
5R01HD096798-05

Brain microRNA-mRNA regulatory networks and alcohol use disorders
08/01/2017 - 07/31/2022 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5R01AA025080-05

Salivary MicroRNAs as Biomarkers for Alcohol Dependence
08/01/2017 - 04/30/2019 (PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
7R21AA023068-03


Association of maternal, fetal and placental biomarkers with neonatal neuroimaging and development following in-utero opioid exposure
09/01/2023 - 08/31/2026 (Subcontract PI)
Boston Medical Center - NIH/National Institute of Child Health and Human Development
1R01HD113143-01

Effects of prenatal opioid exposure on placental DNA methylation and gene expression
03/01/2022 - 02/28/2024 (Subcontract PI)
Boston Medical Center - March of Dimes


Title

Adverse childhood experiences and alcohol misuse in Latino adolescents: Testing biopsychosocial and cultural mechanisms
02/01/2022 - 01/01/2027 (Co-Mentor)
Massachusetts General Hospital - NIH/National Institute on Alcohol Abuse and Alcoholism
K08AA029150-03

Utilization of BioDot Omnia Automated Liquid Dispensing/Handling System to Enhance the Efficiency and Accuracy of High-Throughput Biological Assays
05/01/2025 - 05/01/2026 (Co-Investigator)
PI: Naomi M. Hamburg, MD, MS
NIH NIH
1S10OD038188-01

Single-Nucleus RNA Sequencing Analysis of Transcriptome Changes in the Postmortem Ventral Tegmental Area of Individuals with Alcohol Use Disorder
06/15/2024 - 06/14/2025 (PI)
Boston University Genome Science Institute

Functional validation of 22q11.2 deletion syndrome-associated missense mutation in MRPL40 using CRISPR-Cas9 gene editing
01/01/2022 - 12/31/2022 (PI)
Wing Tat Lee Research Award

Transmission Electron Microscope
06/15/2020 - 06/14/2021 (Co-Investigator)
NIH NIH
1S10OD028571-01

Epigenetic study of cocaine use disorder using a rat model
07/01/2018 - 08/31/2019 (PI)
Boston University CTSI Pilot Award


Yr Title Project-Sub Proj Pubs
2026 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 5R01AA029758-05
2025 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 5R01AA029758-04
2024 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 5R01AA029758-03
2023 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 5R01AA029758-02
2022 Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder 1R01AA029758-01
2020 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-05 13
2019 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-04 13
2018 Brain microRNA-mRNA regulatory networks and alcohol use disorders 5R01AA025080-03 13
2017 Brain microRNA-mRNA regulatory networks and alcohol use disorders 7R01AA025080-02 13
2016 Brain microRNA-mRNA regulatory networks and alcohol use disorders 1R01AA025080-01 13
Showing 10 of 19 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Koo JS, Zhan Q, Zhang H. m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. Environ Epigenet. 2026; 12(1):dvag011. PMID: 41970606; PMCID: PMC13069560; DOI: 10.1093/eep/dvag011;
     
  2. Wang LC, Lu AK, Zhu ZH, Hou WL, Yin X, Yang Q, Man LJ, Chen J, Zhu HL, Yu X, Zhang H, Hui L. Association between reduced plasma dopamine ß-hydroxylase levels and immediate memory impairment in first-episode drug-naïve schizophrenia. Schizophr Res. 2026 Mar; 289:94-99. PMID: 41576833; DOI: 10.1016/j.schres.2026.01.011;
     
  3. Zhu ZH, Wu YM, Wang JJ, Zhang LW, Yin XY, Jia NN, Zhu HH, Cai Y, Hou WL, Yu X, Zhang H, Hui L. Prevalence and cognitive correlates of sleep problems in Chinese patients with first-episode drug-naïve schizophrenia. BMC Psychiatry. 2026 Jan 08; 26(1):127. PMID: 41507882; PMCID: PMC12882125; DOI: 10.1186/s12888-026-07791-x;
     
  4. Ye G, Hou WL, Li J, Man LJ, Zhu ZH, Yin XY, Yu X, Zhang H, Hui L. Association between increased serum TNF-a levels and immediate memory impairment in patients with major depressive disorder: pilot study. BJPsych Open. 2025 Dec 15; 12(1):e16. PMID: 41392773; PMCID: PMC12724106; DOI: 10.1192/bjo.2025.10908;
     
  5. Ngo AL, Nguyen L, Gharavi Alkhansari N, Zhang H. m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. Epigenomes. 2025 Sep 19; 9(3). PMID: 40981072; PMCID: PMC12452703; DOI: 10.3390/epigenomes9030036;
     
  6. Yin XY, Wu YM, Yang Q, Zhu ZH, Hou WL, Wang M, Lv J, Yu X, Zhang H, Hui L. Increased plasma TRANK1 levels in first-episode drug-naïve schizophrenia: Association with delayed memory decline. Asian J Psychiatr. 2025 Nov; 113:104700. PMID: 40972056; DOI: 10.1016/j.ajp.2025.104700;
     
  7. Koo JS, Zhang H. Decoding the role of m6A RNA methylation regulators in psychiatric and substance use disorders. Neurochem Int. 2025 Nov; 190:106035. PMID: 40876784; PMCID: PMC12450308; DOI: 10.1016/j.neuint.2025.106035;
     
  8. Jia N, Yin X, Zhu Z, Hou W, Yang Q, Zhu H, Zhang H, Yu X, Yu Q, Hui L. Comprehensive transcriptome analysis and lncRNA-miRNA-mRNA establishment of schizophrenia based on induced pluripotent stem cells. Schizophr Res. 2025 Jul; 281:22-29. PMID: 40311511; DOI: 10.1016/j.schres.2025.04.027;
     
  9. Koo JS, Zhan Q, Zhang H. Acetaldehyde-driven mRNA methylation and expression changes in ethanol-metabolizing enzyme genes. Epigenetics. 2025 Dec; 20(1):2493865. PMID: 40252050; PMCID: PMC12013419; DOI: 10.1080/15592294.2025.2493865;
     
  10. Cakir B, Tanaka Y, Choe MS, Chu PY, Xiang Y, Kim KY, Zhong M, Gelernter J, Zhang H, Krystal J, Park IH. Functional Validation of Alcohol Dependence-Associated FYN Variants Using Gene Editing and Stem Cell Study Approaches. Int J Stem Cells. 2025 Aug 30; 18(3):263-274. PMID: 40205763; PMCID: PMC12394083; DOI: 10.15283/ijsc24123;
     
Showing 10 of 96 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 96 publications over 24 distinct years, with a maximum of 10 publications in 2025

YearPublications
19961
20021
20041
20062
20074
20082
20093
20104
20112
20128
20136
20144
20159
20167
20177
20182
20195
20205
20211
20223
20234
20242
202510
20263

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Substance Use Disorders
Psychiatric Genetics
Epigenetics
Contact for Mentoring:

72 East Concord Street
Boston MA 02118
Google Map


Zhang's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department